http://new.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2026, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Thu, 13 Aug 2026 08:34:06 -0400 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif http://new.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday http://www.streetinsider.com/Earnings/Pulmatrix+%28PULM%29+Reports+Q2+Loss+of+%240.29/26917139.html <p>Pulmatrix (NASDAQ: PULM) reported Q2 EPS of ($0.29).</p><p>For earnings history and earnings-related data on Pulmatrix (PULM) <a href="http://www.streetinsider.com/ec_earnings.php?q=PULM">click here</a>.</p> http://www.streetinsider.com/Earnings/Pulmatrix+%28PULM%29+Reports+Q2+Loss+of+%240.29/26917139.html Thu, 13 Aug 2026 08:34:06 -0400 PULM http://www.streetinsider.com/SEC+Filings/Form++10-Q+++++++Pulmatrix%2C+Inc.+++++++++++For%3A+Jun+30/26916997.html si-local-file:///var/storage/secattach/20260813/26916997.html http://www.streetinsider.com/SEC+Filings/Form++10-Q+++++++Pulmatrix%2C+Inc.+++++++++++For%3A+Jun+30/26916997.html Thu, 13 Aug 2026 08:21:00 -0400 O.16904700 PULM http://www.streetinsider.com/SEC+Filings/Form++10-Q+++++++Pulmatrix%2C+Inc.+++++++++++For%3A+Jun+30/26916997.html si-local-file:///var/storage/secattach/20260813/26916997.html http://www.streetinsider.com/SEC+Filings/Form++10-Q+++++++Pulmatrix%2C+Inc.+++++++++++For%3A+Jun+30/26916997.html Thu, 13 Aug 2026 08:21:00 -0400 O.16904700 PULM http://www.streetinsider.com/Press+Releases/Pulmatrix+Announces+Second+Quarter+2026+Financial+Results+and+Progress+on+Merger/26916962.html <div class="xn-content"> <p class="prntac"><i>Form S-4 filed related to the announced merger agreement with Eos SENOLYTIX</i></p><p><span class="legendSpanClass"><location value="LU/us.ma.fraham" idsrc="xmltag.org" >FRAMINGHAM, Mass.</location></span>, <span class="legendSpanClass"><chron>Aug. 13, 2026</chron></span> /PRNewswire/ -- <a target="_blank" href="https://edge.prnewswire.com/c/link/?t=0&amp;l=en&amp;o=4751628-1&amp;h=354031260&amp;u=https%3A%2F%2Fc212.net%2Fc%2Flink%2F%3Ft%3D0%26l%3Den%26o%3D2779419-1%26h%3D2224270520%26u%3Dhttp%253A%252F%252Fwww.pulmatrix.com%252F%26a%3DPulmatrix%252C%2BInc.&amp;a=Pulmatrix%2C+Inc." target="_blank" rel="nofollow"><span value="NASDAQ-NMS:PULM" idsrc="xmltag.org" >Pulmatrix, Inc.</span></a> ("<span value="NASDAQ-NMS:PULM" idsrc="xmltag.org" >Pulmatrix</span>" or the "Company") (Nasdaq: PULM), a biopharmaceutical company that has focused on the development of novel inhaled therapeutic products intended to prevent and treat migraine and respiratory diseases with important unmet medical needs using its patented iSPERSE™ technology, today announced its second quarter financial results for 2026 and provided a corporate update related to the merger agreement with Eos SENOLYTIX announced at the end of http://www.streetinsider.com/Press+Releases/Pulmatrix+Announces+Second+Quarter+2026+Financial+Results+and+Progress+on+Merger/26916962.html Thu, 13 Aug 2026 08:15:00 -0400 A.06822034 O.16904700 O.20026344 PULM http://www.streetinsider.com/Press+Releases/Pulmatrix+Announces+Second+Quarter+2026+Financial+Results+and+Progress+on+Merger/26916962.html <div class="xn-content"> <p class="prntac"><i>Form S-4 filed related to the announced merger agreement with Eos SENOLYTIX</i></p><p><span class="legendSpanClass"><location value="LU/us.ma.fraham" idsrc="xmltag.org" >FRAMINGHAM, Mass.</location></span>, <span class="legendSpanClass"><chron>Aug. 13, 2026</chron></span> /PRNewswire/ -- <a target="_blank" href="https://edge.prnewswire.com/c/link/?t=0&amp;l=en&amp;o=4751628-1&amp;h=354031260&amp;u=https%3A%2F%2Fc212.net%2Fc%2Flink%2F%3Ft%3D0%26l%3Den%26o%3D2779419-1%26h%3D2224270520%26u%3Dhttp%253A%252F%252Fwww.pulmatrix.com%252F%26a%3DPulmatrix%252C%2BInc.&amp;a=Pulmatrix%2C+Inc." target="_blank" rel="nofollow"><span value="NASDAQ-NMS:PULM" idsrc="xmltag.org" >Pulmatrix, Inc.</span></a> ("<span value="NASDAQ-NMS:PULM" idsrc="xmltag.org" >Pulmatrix</span>" or the "Company") (Nasdaq: PULM), a biopharmaceutical company that has focused on the development of novel inhaled therapeutic products intended to prevent and treat migraine and respiratory diseases with important unmet medical needs using its patented iSPERSE™ technology, today announced its second quarter financial results for 2026 and provided a corporate update related to the merger agreement with Eos SENOLYTIX announced at the end of http://www.streetinsider.com/Press+Releases/Pulmatrix+Announces+Second+Quarter+2026+Financial+Results+and+Progress+on+Merger/26916962.html Thu, 13 Aug 2026 08:15:00 -0400 A.06822034 O.16904700 O.20026344 PULM http://www.streetinsider.com/Press+Releases/Pulmatrix+Announces+Second+Quarter+2026+Financial+Results+and+Progress+on+Merger/26916962.html <div class="xn-content"> <p class="prntac"><i>Form S-4 filed related to the announced merger agreement with Eos SENOLYTIX</i></p><p><span class="legendSpanClass"><location value="LU/us.ma.fraham" idsrc="xmltag.org" >FRAMINGHAM, Mass.</location></span>, <span class="legendSpanClass"><chron>Aug. 13, 2026</chron></span> /PRNewswire/ -- <a target="_blank" href="https://edge.prnewswire.com/c/link/?t=0&amp;l=en&amp;o=4751628-1&amp;h=354031260&amp;u=https%3A%2F%2Fc212.net%2Fc%2Flink%2F%3Ft%3D0%26l%3Den%26o%3D2779419-1%26h%3D2224270520%26u%3Dhttp%253A%252F%252Fwww.pulmatrix.com%252F%26a%3DPulmatrix%252C%2BInc.&amp;a=Pulmatrix%2C+Inc." target="_blank" rel="nofollow"><span value="NASDAQ-NMS:PULM" idsrc="xmltag.org" >Pulmatrix, Inc.</span></a> ("<span value="NASDAQ-NMS:PULM" idsrc="xmltag.org" >Pulmatrix</span>" or the "Company") (Nasdaq: PULM), a biopharmaceutical company that has focused on the development of novel inhaled therapeutic products intended to prevent and treat migraine and respiratory diseases with important unmet medical needs using its patented iSPERSE™ technology, today announced its second quarter financial results for 2026 and provided a corporate update related to the merger agreement with Eos SENOLYTIX announced at the end of http://www.streetinsider.com/Press+Releases/Pulmatrix+Announces+Second+Quarter+2026+Financial+Results+and+Progress+on+Merger/26916962.html Thu, 13 Aug 2026 08:15:00 -0400 A.06822034 O.16904700 O.20026344 PULM http://www.streetinsider.com/Press+Releases/Pulmatrix+Announces+Second+Quarter+2026+Financial+Results+and+Progress+on+Merger/26916962.html <div class="xn-content"> <p class="prntac"><i>Form S-4 filed related to the announced merger agreement with Eos SENOLYTIX</i></p><p><span class="legendSpanClass"><location value="LU/us.ma.fraham" idsrc="xmltag.org" >FRAMINGHAM, Mass.</location></span>, <span class="legendSpanClass"><chron>Aug. 13, 2026</chron></span> /PRNewswire/ -- <a target="_blank" href="https://edge.prnewswire.com/c/link/?t=0&amp;l=en&amp;o=4751628-1&amp;h=354031260&amp;u=https%3A%2F%2Fc212.net%2Fc%2Flink%2F%3Ft%3D0%26l%3Den%26o%3D2779419-1%26h%3D2224270520%26u%3Dhttp%253A%252F%252Fwww.pulmatrix.com%252F%26a%3DPulmatrix%252C%2BInc.&amp;a=Pulmatrix%2C+Inc." target="_blank" rel="nofollow"><span value="NASDAQ-NMS:PULM" idsrc="xmltag.org" >Pulmatrix, Inc.</span></a> ("<span value="NASDAQ-NMS:PULM" idsrc="xmltag.org" >Pulmatrix</span>" or the "Company") (Nasdaq: PULM), a biopharmaceutical company that has focused on the development of novel inhaled therapeutic products intended to prevent and treat migraine and respiratory diseases with important unmet medical needs using its patented iSPERSE™ technology, today announced its second quarter financial results for 2026 and provided a corporate update related to the merger agreement with Eos SENOLYTIX announced at the end of http://www.streetinsider.com/Press+Releases/Pulmatrix+Announces+Second+Quarter+2026+Financial+Results+and+Progress+on+Merger/26916962.html Thu, 13 Aug 2026 08:15:00 -0400 A.06822034 O.16904700 O.20026344 PULM http://www.streetinsider.com/PRNewswire/Pulmatrix+Announces+Second+Quarter+2026+Financial+Results+and+Progress+on+Merger/26916962.html <div class="xn-content"> <p class="prntac"><i>Form S-4 filed related to the announced merger agreement with Eos SENOLYTIX</i></p><p><span class="legendSpanClass"><location value="LU/us.ma.fraham" idsrc="xmltag.org" >FRAMINGHAM, Mass.</location></span>, <span class="legendSpanClass"><chron>Aug. 13, 2026</chron></span> /PRNewswire/ -- <a target="_blank" href="https://edge.prnewswire.com/c/link/?t=0&amp;l=en&amp;o=4751628-1&amp;h=354031260&amp;u=https%3A%2F%2Fc212.net%2Fc%2Flink%2F%3Ft%3D0%26l%3Den%26o%3D2779419-1%26h%3D2224270520%26u%3Dhttp%253A%252F%252Fwww.pulmatrix.com%252F%26a%3DPulmatrix%252C%2BInc.&amp;a=Pulmatrix%2C+Inc." target="_blank" rel="nofollow"><span value="NASDAQ-NMS:PULM" idsrc="xmltag.org" >Pulmatrix, Inc.</span></a> ("<span value="NASDAQ-NMS:PULM" idsrc="xmltag.org" >Pulmatrix</span>" or the "Company") (Nasdaq: PULM), a biopharmaceutical company that has focused on the development of novel inhaled therapeutic products intended to prevent and treat migraine and respiratory diseases with important unmet medical needs using its patented iSPERSE™ technology, today announced its second quarter financial results for 2026 and provided a corporate update related to the merger agreement with Eos SENOLYTIX announced at the end of http://www.streetinsider.com/PRNewswire/Pulmatrix+Announces+Second+Quarter+2026+Financial+Results+and+Progress+on+Merger/26916962.html Thu, 13 Aug 2026 08:15:00 -0400 A.06822034 O.16904700 O.20026344 PULM http://www.streetinsider.com/PRNewswire/Pulmatrix+Announces+Second+Quarter+2026+Financial+Results+and+Progress+on+Merger/26916962.html <div class="xn-content"> <p class="prntac"><i>Form S-4 filed related to the announced merger agreement with Eos SENOLYTIX</i></p><p><span class="legendSpanClass"><location value="LU/us.ma.fraham" idsrc="xmltag.org" >FRAMINGHAM, Mass.</location></span>, <span class="legendSpanClass"><chron>Aug. 13, 2026</chron></span> /PRNewswire/ -- <a target="_blank" href="https://edge.prnewswire.com/c/link/?t=0&amp;l=en&amp;o=4751628-1&amp;h=354031260&amp;u=https%3A%2F%2Fc212.net%2Fc%2Flink%2F%3Ft%3D0%26l%3Den%26o%3D2779419-1%26h%3D2224270520%26u%3Dhttp%253A%252F%252Fwww.pulmatrix.com%252F%26a%3DPulmatrix%252C%2BInc.&amp;a=Pulmatrix%2C+Inc." target="_blank" rel="nofollow"><span value="NASDAQ-NMS:PULM" idsrc="xmltag.org" >Pulmatrix, Inc.</span></a> ("<span value="NASDAQ-NMS:PULM" idsrc="xmltag.org" >Pulmatrix</span>" or the "Company") (Nasdaq: PULM), a biopharmaceutical company that has focused on the development of novel inhaled therapeutic products intended to prevent and treat migraine and respiratory diseases with important unmet medical needs using its patented iSPERSE™ technology, today announced its second quarter financial results for 2026 and provided a corporate update related to the merger agreement with Eos SENOLYTIX announced at the end of http://www.streetinsider.com/PRNewswire/Pulmatrix+Announces+Second+Quarter+2026+Financial+Results+and+Progress+on+Merger/26916962.html Thu, 13 Aug 2026 08:15:00 -0400 A.06822034 O.16904700 O.20026344 PULM http://www.streetinsider.com/PRNewswire/Pulmatrix+Announces+Second+Quarter+2026+Financial+Results+and+Progress+on+Merger/26916962.html <div class="xn-content"> <p class="prntac"><i>Form S-4 filed related to the announced merger agreement with Eos SENOLYTIX</i></p><p><span class="legendSpanClass"><location value="LU/us.ma.fraham" idsrc="xmltag.org" >FRAMINGHAM, Mass.</location></span>, <span class="legendSpanClass"><chron>Aug. 13, 2026</chron></span> /PRNewswire/ -- <a target="_blank" href="https://edge.prnewswire.com/c/link/?t=0&amp;l=en&amp;o=4751628-1&amp;h=354031260&amp;u=https%3A%2F%2Fc212.net%2Fc%2Flink%2F%3Ft%3D0%26l%3Den%26o%3D2779419-1%26h%3D2224270520%26u%3Dhttp%253A%252F%252Fwww.pulmatrix.com%252F%26a%3DPulmatrix%252C%2BInc.&amp;a=Pulmatrix%2C+Inc." target="_blank" rel="nofollow"><span value="NASDAQ-NMS:PULM" idsrc="xmltag.org" >Pulmatrix, Inc.</span></a> ("<span value="NASDAQ-NMS:PULM" idsrc="xmltag.org" >Pulmatrix</span>" or the "Company") (Nasdaq: PULM), a biopharmaceutical company that has focused on the development of novel inhaled therapeutic products intended to prevent and treat migraine and respiratory diseases with important unmet medical needs using its patented iSPERSE™ technology, today announced its second quarter financial results for 2026 and provided a corporate update related to the merger agreement with Eos SENOLYTIX announced at the end of http://www.streetinsider.com/PRNewswire/Pulmatrix+Announces+Second+Quarter+2026+Financial+Results+and+Progress+on+Merger/26916962.html Thu, 13 Aug 2026 08:15:00 -0400 A.06822034 O.16904700 O.20026344 PULM http://www.streetinsider.com/PRNewswire/Pulmatrix+Announces+Second+Quarter+2026+Financial+Results+and+Progress+on+Merger/26916962.html <div class="xn-content"> <p class="prntac"><i>Form S-4 filed related to the announced merger agreement with Eos SENOLYTIX</i></p><p><span class="legendSpanClass"><location value="LU/us.ma.fraham" idsrc="xmltag.org" >FRAMINGHAM, Mass.</location></span>, <span class="legendSpanClass"><chron>Aug. 13, 2026</chron></span> /PRNewswire/ -- <a target="_blank" href="https://edge.prnewswire.com/c/link/?t=0&amp;l=en&amp;o=4751628-1&amp;h=354031260&amp;u=https%3A%2F%2Fc212.net%2Fc%2Flink%2F%3Ft%3D0%26l%3Den%26o%3D2779419-1%26h%3D2224270520%26u%3Dhttp%253A%252F%252Fwww.pulmatrix.com%252F%26a%3DPulmatrix%252C%2BInc.&amp;a=Pulmatrix%2C+Inc." target="_blank" rel="nofollow"><span value="NASDAQ-NMS:PULM" idsrc="xmltag.org" >Pulmatrix, Inc.</span></a> ("<span value="NASDAQ-NMS:PULM" idsrc="xmltag.org" >Pulmatrix</span>" or the "Company") (Nasdaq: PULM), a biopharmaceutical company that has focused on the development of novel inhaled therapeutic products intended to prevent and treat migraine and respiratory diseases with important unmet medical needs using its patented iSPERSE™ technology, today announced its second quarter financial results for 2026 and provided a corporate update related to the merger agreement with Eos SENOLYTIX announced at the end of http://www.streetinsider.com/PRNewswire/Pulmatrix+Announces+Second+Quarter+2026+Financial+Results+and+Progress+on+Merger/26916962.html Thu, 13 Aug 2026 08:15:00 -0400 A.06822034 O.16904700 O.20026344 PULM http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Pulmatrix%2C+Inc.+++++++++++For%3A+Aug+13/26916969.html si-local-file:///var/storage/secattach/20260813/26916969.html http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Pulmatrix%2C+Inc.+++++++++++For%3A+Aug+13/26916969.html Thu, 13 Aug 2026 08:15:00 -0400 O.16904700 PULM http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Pulmatrix%2C+Inc.+++++++++++For%3A+Aug+13/26916969.html si-local-file:///var/storage/secattach/20260813/26916969.html http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Pulmatrix%2C+Inc.+++++++++++For%3A+Aug+13/26916969.html Thu, 13 Aug 2026 08:15:00 -0400 O.16904700 PULM http://www.streetinsider.com/SEC+Filings/Form++S-3A++++++Pulmatrix%2C+Inc.++++++++++++++++++++++/26892082.html si-local-file:///var/storage/secattach/20260807/26892082.html http://www.streetinsider.com/SEC+Filings/Form++S-3A++++++Pulmatrix%2C+Inc.++++++++++++++++++++++/26892082.html Fri, 07 Aug 2026 17:05:00 -0400 O.16904700 PULM http://www.streetinsider.com/SEC+Filings/Form++S-3A++++++Pulmatrix%2C+Inc.++++++++++++++++++++++/26892082.html si-local-file:///var/storage/secattach/20260807/26892082.html http://www.streetinsider.com/SEC+Filings/Form++S-3A++++++Pulmatrix%2C+Inc.++++++++++++++++++++++/26892082.html Fri, 07 Aug 2026 17:05:00 -0400 O.16904700 PULM http://www.streetinsider.com/SEC+Filings/Form++S-4A++++++Pulmatrix%2C+Inc.++++++++++++++++++++++/26857846.html <p><a target="_blank" href="http://archive.fast-edgar.com/20260803/AB2OIG2CZW2RGZON222Q2ZY2HMWSZZ22Z282">http://archive.fast-edgar.com/20260803/AB2OIG2CZW2RGZON222Q2ZY2HMWSZZ22Z282</a></p> <p> Filed on: August 3, 2026 </p> http://www.streetinsider.com/SEC+Filings/Form++S-4A++++++Pulmatrix%2C+Inc.++++++++++++++++++++++/26857846.html Mon, 03 Aug 2026 16:08:00 -0400 O.16904700 PULM http://www.streetinsider.com/SEC+Filings/Form++S-4A++++++Pulmatrix%2C+Inc.++++++++++++++++++++++/26857846.html <p><a target="_blank" href="http://archive.fast-edgar.com/20260803/AB2OIG2CZW2RGZON222Q2ZY2HMWSZZ22Z282">http://archive.fast-edgar.com/20260803/AB2OIG2CZW2RGZON222Q2ZY2HMWSZZ22Z282</a></p> <p> Filed on: August 3, 2026 </p> http://www.streetinsider.com/SEC+Filings/Form++S-4A++++++Pulmatrix%2C+Inc.++++++++++++++++++++++/26857846.html Mon, 03 Aug 2026 16:08:00 -0400 O.16904700 PULM http://www.streetinsider.com/SEC+Filings/Form++S-4++++++++Pulmatrix%2C+Inc.++++++++++++++++++++++/26753261.html <p><a target="_blank" href="http://archive.fast-edgar.com/20260709/AK22G22CZW2RMTU2222H2ZY2WBIQRZ22Q282">http://archive.fast-edgar.com/20260709/AK22G22CZW2RMTU2222H2ZY2WBIQRZ22Q282</a></p> <p> Filed on: July 9, 2026 </p> http://www.streetinsider.com/SEC+Filings/Form++S-4++++++++Pulmatrix%2C+Inc.++++++++++++++++++++++/26753261.html Thu, 09 Jul 2026 16:06:00 -0400 O.16904700 PULM http://www.streetinsider.com/SEC+Filings/Form++S-4++++++++Pulmatrix%2C+Inc.++++++++++++++++++++++/26753261.html <p><a target="_blank" href="http://archive.fast-edgar.com/20260709/AK22G22CZW2RMTU2222H2ZY2WBIQRZ22Q282">http://archive.fast-edgar.com/20260709/AK22G22CZW2RMTU2222H2ZY2WBIQRZ22Q282</a></p> <p> Filed on: July 9, 2026 </p> http://www.streetinsider.com/SEC+Filings/Form++S-4++++++++Pulmatrix%2C+Inc.++++++++++++++++++++++/26753261.html Thu, 09 Jul 2026 16:06:00 -0400 O.16904700 PULM http://www.streetinsider.com/SEC+Filings/Form++10-KA+++++Pulmatrix%2C+Inc.+++++++++++For%3A+Dec+31/26654663.html si-local-file:///var/storage/secattach/20260616/26654663.html http://www.streetinsider.com/SEC+Filings/Form++10-KA+++++Pulmatrix%2C+Inc.+++++++++++For%3A+Dec+31/26654663.html Tue, 16 Jun 2026 16:37:00 -0400 O.16904700 PULM http://www.streetinsider.com/SEC+Filings/Form++10-KA+++++Pulmatrix%2C+Inc.+++++++++++For%3A+Dec+31/26654663.html si-local-file:///var/storage/secattach/20260616/26654663.html http://www.streetinsider.com/SEC+Filings/Form++10-KA+++++Pulmatrix%2C+Inc.+++++++++++For%3A+Dec+31/26654663.html Tue, 16 Jun 2026 16:37:00 -0400 O.16904700 PULM http://www.streetinsider.com/SEC+Filings/Form++425++++++++Pulmatrix%2C+Inc.++++++++++++++++++++++++Filed+by%3A+Pulmatrix%2C+Inc./26608488.html si-local-file:///var/storage/secattach/20260605/26608488.html http://www.streetinsider.com/SEC+Filings/Form++425++++++++Pulmatrix%2C+Inc.++++++++++++++++++++++++Filed+by%3A+Pulmatrix%2C+Inc./26608488.html Fri, 05 Jun 2026 08:00:00 -0400 O.16904700 PULM http://www.streetinsider.com/SEC+Filings/Form++425++++++++Pulmatrix%2C+Inc.++++++++++++++++++++++++Filed+by%3A+Pulmatrix%2C+Inc./26608488.html si-local-file:///var/storage/secattach/20260605/26608488.html http://www.streetinsider.com/SEC+Filings/Form++425++++++++Pulmatrix%2C+Inc.++++++++++++++++++++++++Filed+by%3A+Pulmatrix%2C+Inc./26608488.html Fri, 05 Jun 2026 08:00:00 -0400 O.16904700 PULM http://www.streetinsider.com/SEC+Filings/Form++S-3++++++++Pulmatrix%2C+Inc.++++++++++++++++++++++/26601988.html si-local-file:///var/storage/secattach/20260604/26601988.html http://www.streetinsider.com/SEC+Filings/Form++S-3++++++++Pulmatrix%2C+Inc.++++++++++++++++++++++/26601988.html Thu, 04 Jun 2026 06:11:00 -0400 O.16904700 PULM http://www.streetinsider.com/SEC+Filings/Form++S-3++++++++Pulmatrix%2C+Inc.++++++++++++++++++++++/26601988.html si-local-file:///var/storage/secattach/20260604/26601988.html http://www.streetinsider.com/SEC+Filings/Form++S-3++++++++Pulmatrix%2C+Inc.++++++++++++++++++++++/26601988.html Thu, 04 Jun 2026 06:11:00 -0400 O.16904700 PULM